Novasep Process Names Stephen K Tingley to Head Global Sales & Marketing for its Recently Launched Biopharma Division
14 March 2007
Well established as the market leader in preparative HPLC for protein polishing, chiral separations and small molecule polishing, Novasep Process recently streamlined its businesses into three market focused business units: the established Novasep Process Pharma and Industrial Biotechnology Divisions, and the newly created Biopharma Division.
With more than twenty years of biopharmaceutical industry experience in general management, sales, marketing, and business development; Mr. Stephen Tingley brings to Novasep Process an intimate knowledge of the biotechnology industry, needs, people and processes. Steve has assumed the role of Vice President, Sales & Marketing for the Biopharma Division.
Prior to joining Novasep in February 2007, Mr. Tingley worked for BioProcessors Corporation and Millipore Corporation. Steve has been successfully associated with biopharmaceutical process development and manufacturing having led the marketing and commercialization of several innovative purification and separation technologies.
In welcoming Mr Tingley, Mr Thierry Favreau, President of Novasep Process notes: "Steve is well known in the biopharmaceutical industry, he has the trust and respect of many of the industries' leading scientists. He has shown himself to be both a technologist and a marketer, which will be critical to developing partnerships between Novasep Biopharma and the biopharmaceutical manufacturing community. It is through such successful partnerships that Novasep's innovative purification technologies will be introduced over the coming months and will gain industry acceptance by demonstrating their capability to deliver significant and tangible benefits to our future clients".
ABOUT GROUPE NOVASEP
Novasep Process specialises in solving purification challenges for the pharmaceutical, biopharmaceutical and industrial biotech markets. The company offers laboratory purification equipment as well as large-scale industrial production plants for producing pure products, and a full range of services including process development, multi-ton scale custom purification and performance optimisation.
To serve its different markets, Novasep Process offers innovative and reliable solutions based on Novasep Process proprietary technologies: Novasep chromatography (high and low pressure) and crystallization, Applexion ion exchange and evaporation, Orelis membrane processes.
Groupe Novasep, with its headquarters near Nancy (in eastern France), works with the pharmaceutical, food, cosmetics, agrochemicals, and specialty chemicals industries through its two business segments – Novasep Process and Novasep Synthesis. Both strategic businesses are complementary organisations with skills designed to provide technically optimised and economical solutions for the life-science sector and related industries.
